A clean, transparent view of Boutique Gardens' financials, deal terms and go-to-market strategy. All figures below are modeled on the bare-minimum production allowed under our 3,100 sq ft, 1,000 lb on-premise licensed facility to keep expectations realistic.
Range reflects buildout with or without the on-site kitchen.
Capital secures the licensed facility, funds specialized processing infrastructure (hash rosin, automated vape filling) and provides six months of operational runway through first sale.
All investors must have committed capital investment-ready at the time of close and must be able to pass a New Jersey state background check as required by the Cannabis Regulatory Commission. Prior cannabis-related charges do not disqualify an investor. Other financial crimes (fraud, embezzlement, money laundering) or hard-drug convictions may affect eligibility under state licensing rules.
Annualized Year 1 revenue potential for each product line — with the exact production spec, per-unit cost of production and per-unit sale price under both go-to-market models. Dispensary shelf prices are shown as a reference point.
South Jersey manufacturing facility with new construction, 10' ceilings, 2×4 metal studs with insulation, mini-split HVAC throughout, dedicated kitchen with odor mitigation, hash washing room, secure product storage and drive-in receiving.

Approved floor plan · New construction · 10' ceiling · NJ code compliant
Fixed overhead and cost of goods (the cost of purchasing raw flower) stay flat across both models. Shifting from wholesaling to licensed retail stores over to direct-to-consumer delivery meaningfully increases post-tax cash flow on identical production volumes. Figures reflect the bare-minimum throughput allowed under the license and are annualized over the first 12 months of full operations.
Same across both models
Same across both models
Forward-looking statements · For discussion purposes only · Not an offer to sell securities
This offering is limited to accredited investors as defined under Rule 501 of Regulation D. Verification of accreditation is required prior to closing.
$400,000 to $600,000 in seed capital, with a $100,000 minimum investment. Up to 40% equity is being offered for the full $600,000 raise, or 6.67% equity per $100,000 ticket. Capital secures the 3,100 sq ft South Jersey facility, builds out processing infrastructure and funds six months of operational runway to first sale.
Base-case projections show $640K–$1.82M in post-tax cash flow within the first full 12 months of operations, depending on the wholesale vs. direct-to-consumer model — a rapid payback period against a $400K–$600K seed injection. First revenue is expected within roughly six months of close.
Model A sells wholesale to licensed New Jersey retail stores (dispensaries) — simpler logistics and a stable revenue floor. Model B delivers finished product directly to end consumers, capturing full retail margins on identical production.
All figures are modeled on the bare-minimum production allowed under our license. The 3,100 sq ft facility is authorized to hold up to 1,000 lbs of flower on premises, leaving significant upside above the numbers shown.
Regulatory shifts, wholesale price compression and 280E federal tax exposure. A full risk factors disclosure is provided in the private placement memorandum.
Submit a request through the contact form. Our team will follow up within two business days to arrange an intro call and share the data room.
The complete pitch deck includes company overview, product breakdown, market analysis, unit economics and detailed financials.